Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Return on Invested Capital (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Return on Invested Capital over the past 14 years, most recently at 0.13% for Q2 2025.

  • Quarterly results put Return on Invested Capital at 0.13% for Q2 2025, down 6.0% from a year ago — trailing twelve months through May 2025 was 0.13% (down 6.0% YoY), and the annual figure for FY2025 was 0.13%, down 5.0%.
  • Return on Invested Capital for Q2 2025 was 0.13% at Lifecore Biomedical, Inc. \De\, up from 0.16% in the prior quarter.
  • Over the last five years, Return on Invested Capital for LFCR hit a ceiling of 0.01% in Q3 2022 and a floor of 0.35% in Q3 2023.
  • Median Return on Invested Capital over the past 5 years was 0.06% (2022), compared with a mean of 0.1%.
  • Biggest five-year swings in Return on Invested Capital: tumbled -36bps in 2023 and later increased 25bps in 2024.
  • Lifecore Biomedical, Inc. \De\'s Return on Invested Capital stood at 0.01% in 2021, then plummeted by -300bps to 0.05% in 2022, then crashed by -410bps to 0.28% in 2023, then skyrocketed by 61bps to 0.11% in 2024, then dropped by -23bps to 0.13% in 2025.
  • The last three reported values for Return on Invested Capital were 0.13% (Q2 2025), 0.16% (Q1 2025), and 0.11% (Q4 2024) per Business Quant data.